Always private
DuckDuckGo never tracks your searches.
Learn More
You can hide this reminder in Search Settings
All regions
Argentina
Australia
Austria
Belgium (fr)
Belgium (nl)
Brazil
Bulgaria
Canada (en)
Canada (fr)
Catalonia
Chile
China
Colombia
Croatia
Czech Republic
Denmark
Estonia
Finland
France
Germany
Greece
Hong Kong
Hungary
Iceland
India (en)
Indonesia (en)
Ireland
Israel (en)
Italy
Japan
Korea
Latvia
Lithuania
Malaysia (en)
Mexico
Netherlands
New Zealand
Norway
Pakistan (en)
Peru
Philippines (en)
Poland
Portugal
Romania
Russia
Saudi Arabia
Singapore
Slovakia
Slovenia
South Africa
Spain (ca)
Spain (es)
Sweden
Switzerland (de)
Switzerland (fr)
Taiwan
Thailand (en)
Turkey
Ukraine
United Kingdom
US (English)
US (Spanish)
Vietnam (en)
Safe search: moderate
Strict
Moderate
Off
Any time
Any time
Past day
Past week
Past month
Past year
  1. pmsmattrain.eu

    Overview of our Programme PMSMatTrain focuses on gaining a comprehensive understanding of the progressive phase of multiple sclerosis (PMS) from basics to translation, fully supported by eight beneficiaries (six research institutions and two SMEs).
    • Our Fellows

      Fellows Bhavya Ojha obtained her BSc in Neuroscience from Dalhousie University, Canada, and an MSc in Molecular bioscience (majors: Neuroscience) from Heidelberg University, Germany. Her MSc thesis focused on impact of chronic neuropathic pain on attention in mice. In the PMSMatTrain project, her research focuses on progressive multiple sclerosis and assessing potential therapy delivered via ...

  2. pmsmattrain.eu

    Her research focus is to develop and validate the therapeutic efficacy of a novel device housing a multi-modal hydrogel using iPSC derived in vitro models of multiple sclerosis. Within PMSMatTrain she is working under the supervision of Prof. Tanja Kuhlmann at the Institute of Neuropathology, University Hospital Münster, Germany (WWU).
  3. dementianetwork.ie

    PMSMatTrain focuses on gaining a comprehensive understanding of the progressive phase of multiple sclerosis (PMS) from basics to translation, fully supported by eight beneficiaries (six research institutions and two SMEs). The consortium will develop a multi-modal "tuneable" hydrogel-based medical device designed to bring about biphasic release of anti-inflammatory molecules and ...
  4. cordis.europa.eu

    Oct 28, 2024Wiley 10.1002/glia.24419 Molecular Mechanisms of Physiological and Pathophysiological Processes inMultiple Sclerosis-like Models Ex Vivo and In Vivo Maurine Fucito European Neuroscience Conference by Doctoral Students-Posters, 2021, Page (s) P6A25 Brain Proteomic Signatures of an in vivo Model of Multiple Sclerosis
  5. cordis.europa.eu

    The consortium is expecting exploitation of the research results in the form of novel approaches for the treatment of neurodegenerative diseases including multiple sclerosis and Alzheimer's disease. All consortium members experienced delays in their research due to the global COVID pandemic.
  6. pubmed.ncbi.nlm.nih.gov

    Type I interferons (IFN), including IFNβ, play a protective role in multiple sclerosis (MS) and its animal model, experimental autoimmune encephalomyelitis (EAE). Type I IFNs are induced by the stimulation of innate signaling, including via cytoplasmic RIG-I-like receptors. In the present study, we …
  7. pmsmattrain.eu

    Fellows Bhavya Ojha obtained her BSc in Neuroscience from Dalhousie University, Canada, and an MSc in Molecular bioscience (majors: Neuroscience) from Heidelberg University, Germany. Her MSc thesis focused on impact of chronic neuropathic pain on attention in mice. In the PMSMatTrain project, her research focuses on progressive multiple sclerosis and assessing potential therapy delivered via ...

    Can’t find what you’re looking for?

    Help us improve DuckDuckGo searches with your feedback

Custom date rangeX